Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Altamura

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Biochemistry|October 21, 2000
Optimization of the P'-region of peptide inhibitors of hepatitis C virus NS3/4A proteaseP Ingallinella, E Bianchi, R Ingenito, et al.
Peptide Research|January 1, 1994
A Multimeric Synthetic Peptide Combinatorial LibraryA Wallace, S Altamura, C Toniatti, et al.
The Journal of General Virology|February 17, 2000
Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequenceL Tomei, R L Vitale, I Incitti, et al.
Journal of Bacteriology|July 1, 1986
Unique antibiotic sensitivity of archaebacterial polypeptide elongation factorsP Londei, J L Sanz, S Altamura, et al.
Endocrinology|January 1, 1989
Identification of immunoreactive gastrin-releasing peptide related substances in adult rat Leydig cellsL Gnessi, A Isidori, M Bolotti, et al.
Molecular and Cellular Endocrinology|September 1, 1989
Gastrin-releasing peptide-like immunoreactivity in porcine follicular fluid and ovaryL Gnessi, S Altamura, M Arizzi, et al.
The EMBO Journal|December 15, 1994
Rational design of a receptor super-antagonist of human interleukin-6R Savino, L Ciapponi, A Lahm, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
Biochemistry|June 24, 1998
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage productsP Ingallinella, S Altamura, E Bianchi, et al.
Circulation|September 1, 1996
Elevated levels of interleukin-6 in unstable anginaL M Biasucci, A Vitelli, G Liuzzo, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Biochemistry|October 21, 2000
Optimization of the P'-region of peptide inhibitors of hepatitis C virus NS3/4A proteaseP Ingallinella, E Bianchi, R Ingenito, et al.
Peptide Research|January 1, 1994
A Multimeric Synthetic Peptide Combinatorial LibraryA Wallace, S Altamura, C Toniatti, et al.
The Journal of General Virology|February 17, 2000
Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequenceL Tomei, R L Vitale, I Incitti, et al.
Journal of Bacteriology|July 1, 1986
Unique antibiotic sensitivity of archaebacterial polypeptide elongation factorsP Londei, J L Sanz, S Altamura, et al.
Endocrinology|January 1, 1989
Identification of immunoreactive gastrin-releasing peptide related substances in adult rat Leydig cellsL Gnessi, A Isidori, M Bolotti, et al.
Molecular and Cellular Endocrinology|September 1, 1989
Gastrin-releasing peptide-like immunoreactivity in porcine follicular fluid and ovaryL Gnessi, S Altamura, M Arizzi, et al.
The EMBO Journal|December 15, 1994
Rational design of a receptor super-antagonist of human interleukin-6R Savino, L Ciapponi, A Lahm, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
Biochemistry|June 24, 1998
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage productsP Ingallinella, S Altamura, E Bianchi, et al.
Circulation|September 1, 1996
Elevated levels of interleukin-6 in unstable anginaL M Biasucci, A Vitelli, G Liuzzo, et al.
Pageof 3